Clinical Research Practice And Prospects (Pb 2019). Questo articolo non è disponibile.
Lingua: inglese
Editore: CBS Publishers & Distributors Pvt Ltd, India, 2019
- Brossura
- Nuovo
Da: SMASS Sellers, IRVING, TX, U.S.A.SMASS Sellers
Venditore con 4 stelle
Venditore AbeBooks dal 22 febbraio 2022
Non disponibile
Brossura
Condizione: Nuovo
EUR 34,27
Descrizione dell’articolo da parte del venditore
Brand New, Softcover edition. This item may ship from the US or our Overseas warehouse depending on your location and stock availability.
Codice articolo SNTA-63434
- Titolo
- Clinical Research Practice And Prospects (Pb 2019)
- Autore
- Pal, T.K.
- Editore
- CBS Publishers & Distributors Pvt Ltd, India
- Anno di pubblicazione
- 2019
- Condizione
- New
- Rilegatura
- Brossura
- Lingua
- inglese
- ISBN 10
- 812391685X
- ISBN 13
- 9788123916859
The book discusses the guidelines, methodology and instrumental techniques under the framework of regulatory affairs for clinical research, which will be of immense help to the students, scholars, scientists and executives of the pharmaceutical industries who will be rendering services to this specific area of pharmacokinetics and pharmacodynamics.
The appendix at the end of the book provides the standard protocols for carrying out bioequivalence study, toxicity study, and clinical trial as formulated by the regulatory authorities of FDA. These protocols are of immense help to the practising executives and scientists. The distinguished contributors have made their best efforts in sharing their experiences and knowledge to accelerate the growth and development of pharmaceutical industries and to drive India to a golden hub of clinical research.
The appendix at the end of the book provides the standard protocols for carrying out bioequivalence study, toxicity study, and clinical trial as formulated by the regulatory authorities of FDA. These protocols are of immense help to the practising executives and scientists. The distinguished contributors have made their best efforts in sharing their experiences and knowledge to accelerate the growth and development of pharmaceutical industries and to drive India to a golden hub of clinical research.
"Riassunto" può appartenere a un’altra edizione di questo titolo.